Om avsnittet
Dr Emma Johnson talks to Rob Calder about shared genetic liabilities for cannabis use disorder and schizophrenia and the role of tobacco smoking. Dr Johnson talks about the implications of this research on the evidence for a causal relationship between cannabis and schizophrenia and for other genetic associations relating to substance use and psychiatric disorders. The episode also covers to ever-fascinating issue of mendelian randomisation. (Be sure to check out episode 22 too!)Johnson E.C., Hatoum A.S., Deak J.D., Polimanti R, Murray R.M., Edenberg H.J., et al. The relationship between cannabis and schizophrenia: a genetically informed perspective. Addiction 2021 }https://doi.org/10.1111/add.15534 Hosted on Acast. See acast.com/privacy for more information.
Senaste avsnitten
Cannabis potency and psychotic experiences with Lindsey Hines
Cannabis use in the US with Jonathan Caulkins
Integrated care vans with Kathleen Page
Smoking and abdominal obesity with Germán Carrasquilla
Benzodiazepines and treatment with Adam Bakker, Michael Liebrenz and Alexander Smith
Contingency management with Gabriela Khazanov, James, McKay and Richard Rawson
Xylazine, heroin and drug markets with Caroline Copeland
Synthetic opioid production in Europe with Paul Griffiths
Alcohol-free drinks in the US with Molly Bowdring